Monthly Archives: February 2017

Massachusetts General Hospital (MGH) Study Informs for Medulloblastoma patients

February 27th, 2017|

Massachusetts General Hospital (MGH) researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma. In their report published […]

Pediatric Low Grade Gliomas: Implications of the Biologic Era

February 16th, 2017|

International Panel of Pediatric Brain Cancer Experts find Consensus on how to best integrate the growing body of molecular genetic information into tumor classifications and, more importantly, for future […]

Two new trials for pediatric brain cancer open at UTHealth/Children’s Memorial Hermann

February 6th, 2017|

Pediatric neurosurgeon Dr. David Sandberg of McGovern Medical School at UTHealth has pioneered administering chemotherapy in the fourth ventricle of the brain for pediatric brain cancers.   The pilot trials, […]

Publications GALORE in 2016 for DFCI Researchers

February 1st, 2017|

With the support of the PLGA fund-raising community, DFCI researchers had an explosive year in 2016 with discoveries in pediatric brain cancer research which impact a wide array of […]